- 2022
- 2021
- 2020
HISTORY
Creating the world where anyone can benefit from high-quality medical care through the development of medical technology
-
2022
- 05
-
Certified ISO 13485
- 03
-
Joint Research with Daegu Catholic Univ. Medical Center
-
2021
- 11
-
Approval as a manufacturer of medical devices. (MFDS, Republic of Korea)
- 10
-
Contract for ‘MediLabel’ with the Ewha Womans University Mokdong Hospital
- 09
-
Secured series Pre-A investment
- 07
-
Change of company name to INGRADIENT
- 06
-
Contract for ‘MediLabel’ with the Asan Medical Center
Contract for ‘MediLabel’ with the Jeonbuk National University College of Veterinary Medicine
- 05
-
Joint research with Daegu Catholic University Medical Center
- 04
-
Investment agreement with global investment group YOZMA Group.
- 03
-
Investment agreement with NEXTRANS
Investment agreement with Vision Creator
-
2020
- 11
-
Contract for ‘MediLabel’ with the Seoul National University Bundang Hospital(Radiology)
- 07
-
Contract for ‘MediLabel’ with the Catholic University of Korea, Seoul ST. Mary’s Hospital
- 06
-
Contract for ‘MediLabel’ with the Seoul National University Hospital
Contract for ‘MediLabel’ with the Catholic University of Korea, Institute of biomedical industry
- 04
-
Joint research with Jeju National University Hospital
Contract for front-end process system development with the SAMSUNG Electro-Mechanics
- 03
-
Establish J.AI Labs R&D Center
Joint research with Research Institute of Advanced Technology, Jeju National University
Joint research with SAMSUNG Medical Center(Nuclear Medicine)
Joint research with SEVERANCE Hospital
- 01
-
Launch ‘MediLabel’ prototype
Incorporation of company(J.AI Labs)